[
  {
    "sentence": "Because of this bidirectional transfer of cells, a woman may host cells of fetal origin from her pregnancies and cells of maternal origin from her own mother (Figure 1).2 Furthermore, the same woman might host other cells transferred from her mother during fetal life, including cells possibly stemming from older siblings, a vanishing twin, or prior maternal termination of pregnancy,2,8,9 and even cells of neither fetal nor maternal origin stemming from maternal blood transfusion.9 Not all papers, however, demonstrate increased cFMC of older sibling origin, and further research is needed to uncover all potential sources of microchimerism in women.10\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "With both methods, the Y-chromosome is still often employed as a target for identifying microchimeric cells (Figure 2).2 FISH visualizes the cells in the context of surrounding maternal tissue, but is costly and time consuming.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Real-time PCR is simpler and more time efficient.11 With either method, the researcher may compare not only the prevalence of cFMC in different groups but also whether the relative quantities of cFMC differ in each subject (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This allows for microchimerism detection by FISH or by qPCR probes targeting the Y-chromosome (as shown here).Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "These probes are used to target paternally inherited fetal DNA sequences that the mother does not possess (Figure 4), thereby detecting microchimerism from male and female fetuses.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Boddy et al. hypothesize that cFMC may affect lactation, maternal thermoregulation, and mother–child bonding.6 Firstly, they cite a study showing that fetal microchimeric fibroblasts from mice differentiate into mammary epithelial cells when exposed to lactation hormones in vitro46 and another study showing that 56% of healthy parous women carry cFMC in their mammary tissue.47 Secondly, they present evidence that cFMC persists after pregnancy in maternal thyroid tissue48 and speculate that fetal cells may upregulate maternal body temperature in women with newborn infants.6 Finally, based on evidence that fetal cells in maternal mouse brains can differentiate into mature neurons49 and that cFMC may be found in the female human brain,50 they propose an evolutionary role for cFMC in strengthening the emotional tie between mother and child.6The impact of cFMC in inducing immunotolerance during pregnancy and temporary secondary effects on autoimmune disease\nIn addition to modulating maternal body function postpartum, maternal acquisition of fetal genetic material has been proposed to play a role in inducing materno-fetal tolerance during pregnancy, a factor potentially contributing to why certain autoimmune diseases, like rheumatoid arthritis (RA), are temporarily ameliorated during pregnancy.24 In 1993, a study by Nelson et al. looked into fetal–maternal disparity in HLA class II molecules,51 a concept illustrated in Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Because of this bidirectional transfer of cells, a woman may host cells of fetal origin from her pregnancies and cells of maternal origin from her own mother (Figure 1).2 Furthermore, the same woman might host other cells transferred from her mother during fetal life, including cells possibly stemming from older siblings, a vanishing twin, or prior maternal termination of pregnancy,2,8,9 and even cells of neither fetal nor maternal origin stemming from maternal blood transfusion.9 Not all papers, however, demonstrate increased cFMC of older sibling origin, and further research is needed to uncover all potential sources of microchimerism in women.10\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "With both methods, the Y-chromosome is still often employed as a target for identifying microchimeric cells (Figure 2).2 FISH visualizes the cells in the context of surrounding maternal tissue, but is costly and time consuming.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Real-time PCR is simpler and more time efficient.11 With either method, the researcher may compare not only the prevalence of cFMC in different groups but also whether the relative quantities of cFMC differ in each subject (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This allows for microchimerism detection by FISH or by qPCR probes targeting the Y-chromosome (as shown here).Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "These probes are used to target paternally inherited fetal DNA sequences that the mother does not possess (Figure 4), thereby detecting microchimerism from male and female fetuses.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Boddy et al. hypothesize that cFMC may affect lactation, maternal thermoregulation, and mother–child bonding.6 Firstly, they cite a study showing that fetal microchimeric fibroblasts from mice differentiate into mammary epithelial cells when exposed to lactation hormones in vitro46 and another study showing that 56% of healthy parous women carry cFMC in their mammary tissue.47 Secondly, they present evidence that cFMC persists after pregnancy in maternal thyroid tissue48 and speculate that fetal cells may upregulate maternal body temperature in women with newborn infants.6 Finally, based on evidence that fetal cells in maternal mouse brains can differentiate into mature neurons49 and that cFMC may be found in the female human brain,50 they propose an evolutionary role for cFMC in strengthening the emotional tie between mother and child.6The impact of cFMC in inducing immunotolerance during pregnancy and temporary secondary effects on autoimmune disease\nIn addition to modulating maternal body function postpartum, maternal acquisition of fetal genetic material has been proposed to play a role in inducing materno-fetal tolerance during pregnancy, a factor potentially contributing to why certain autoimmune diseases, like rheumatoid arthritis (RA), are temporarily ameliorated during pregnancy.24 In 1993, a study by Nelson et al. looked into fetal–maternal disparity in HLA class II molecules,51 a concept illustrated in Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Because of this bidirectional transfer of cells, a woman may host cells of fetal origin from her pregnancies and cells of maternal origin from her own mother (Figure 1).2 Furthermore, the same woman might host other cells transferred from her mother during fetal life, including cells possibly stemming from older siblings, a vanishing twin, or prior maternal termination of pregnancy,2,8,9 and even cells of neither fetal nor maternal origin stemming from maternal blood transfusion.9 Not all papers, however, demonstrate increased cFMC of older sibling origin, and further research is needed to uncover all potential sources of microchimerism in women.10\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "With both methods, the Y-chromosome is still often employed as a target for identifying microchimeric cells (Figure 2).2 FISH visualizes the cells in the context of surrounding maternal tissue, but is costly and time consuming.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Real-time PCR is simpler and more time efficient.11 With either method, the researcher may compare not only the prevalence of cFMC in different groups but also whether the relative quantities of cFMC differ in each subject (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This allows for microchimerism detection by FISH or by qPCR probes targeting the Y-chromosome (as shown here).Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "These probes are used to target paternally inherited fetal DNA sequences that the mother does not possess (Figure 4), thereby detecting microchimerism from male and female fetuses.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Boddy et al. hypothesize that cFMC may affect lactation, maternal thermoregulation, and mother–child bonding.6 Firstly, they cite a study showing that fetal microchimeric fibroblasts from mice differentiate into mammary epithelial cells when exposed to lactation hormones in vitro46 and another study showing that 56% of healthy parous women carry cFMC in their mammary tissue.47 Secondly, they present evidence that cFMC persists after pregnancy in maternal thyroid tissue48 and speculate that fetal cells may upregulate maternal body temperature in women with newborn infants.6 Finally, based on evidence that fetal cells in maternal mouse brains can differentiate into mature neurons49 and that cFMC may be found in the female human brain,50 they propose an evolutionary role for cFMC in strengthening the emotional tie between mother and child.6The impact of cFMC in inducing immunotolerance during pregnancy and temporary secondary effects on autoimmune disease\nIn addition to modulating maternal body function postpartum, maternal acquisition of fetal genetic material has been proposed to play a role in inducing materno-fetal tolerance during pregnancy, a factor potentially contributing to why certain autoimmune diseases, like rheumatoid arthritis (RA), are temporarily ameliorated during pregnancy.24 In 1993, a study by Nelson et al. looked into fetal–maternal disparity in HLA class II molecules,51 a concept illustrated in Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Because of this bidirectional transfer of cells, a woman may host cells of fetal origin from her pregnancies and cells of maternal origin from her own mother (Figure 1).2 Furthermore, the same woman might host other cells transferred from her mother during fetal life, including cells possibly stemming from older siblings, a vanishing twin, or prior maternal termination of pregnancy,2,8,9 and even cells of neither fetal nor maternal origin stemming from maternal blood transfusion.9 Not all papers, however, demonstrate increased cFMC of older sibling origin, and further research is needed to uncover all potential sources of microchimerism in women.10\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "With both methods, the Y-chromosome is still often employed as a target for identifying microchimeric cells (Figure 2).2 FISH visualizes the cells in the context of surrounding maternal tissue, but is costly and time consuming.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Real-time PCR is simpler and more time efficient.11 With either method, the researcher may compare not only the prevalence of cFMC in different groups but also whether the relative quantities of cFMC differ in each subject (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This allows for microchimerism detection by FISH or by qPCR probes targeting the Y-chromosome (as shown here).Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "These probes are used to target paternally inherited fetal DNA sequences that the mother does not possess (Figure 4), thereby detecting microchimerism from male and female fetuses.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Boddy et al. hypothesize that cFMC may affect lactation, maternal thermoregulation, and mother–child bonding.6 Firstly, they cite a study showing that fetal microchimeric fibroblasts from mice differentiate into mammary epithelial cells when exposed to lactation hormones in vitro46 and another study showing that 56% of healthy parous women carry cFMC in their mammary tissue.47 Secondly, they present evidence that cFMC persists after pregnancy in maternal thyroid tissue48 and speculate that fetal cells may upregulate maternal body temperature in women with newborn infants.6 Finally, based on evidence that fetal cells in maternal mouse brains can differentiate into mature neurons49 and that cFMC may be found in the female human brain,50 they propose an evolutionary role for cFMC in strengthening the emotional tie between mother and child.6The impact of cFMC in inducing immunotolerance during pregnancy and temporary secondary effects on autoimmune disease\nIn addition to modulating maternal body function postpartum, maternal acquisition of fetal genetic material has been proposed to play a role in inducing materno-fetal tolerance during pregnancy, a factor potentially contributing to why certain autoimmune diseases, like rheumatoid arthritis (RA), are temporarily ameliorated during pregnancy.24 In 1993, a study by Nelson et al. looked into fetal–maternal disparity in HLA class II molecules,51 a concept illustrated in Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Because of this bidirectional transfer of cells, a woman may host cells of fetal origin from her pregnancies and cells of maternal origin from her own mother (Figure 1).2 Furthermore, the same woman might host other cells transferred from her mother during fetal life, including cells possibly stemming from older siblings, a vanishing twin, or prior maternal termination of pregnancy,2,8,9 and even cells of neither fetal nor maternal origin stemming from maternal blood transfusion.9 Not all papers, however, demonstrate increased cFMC of older sibling origin, and further research is needed to uncover all potential sources of microchimerism in women.10\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "With both methods, the Y-chromosome is still often employed as a target for identifying microchimeric cells (Figure 2).2 FISH visualizes the cells in the context of surrounding maternal tissue, but is costly and time consuming.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Real-time PCR is simpler and more time efficient.11 With either method, the researcher may compare not only the prevalence of cFMC in different groups but also whether the relative quantities of cFMC differ in each subject (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This allows for microchimerism detection by FISH or by qPCR probes targeting the Y-chromosome (as shown here).Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "These probes are used to target paternally inherited fetal DNA sequences that the mother does not possess (Figure 4), thereby detecting microchimerism from male and female fetuses.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Boddy et al. hypothesize that cFMC may affect lactation, maternal thermoregulation, and mother–child bonding.6 Firstly, they cite a study showing that fetal microchimeric fibroblasts from mice differentiate into mammary epithelial cells when exposed to lactation hormones in vitro46 and another study showing that 56% of healthy parous women carry cFMC in their mammary tissue.47 Secondly, they present evidence that cFMC persists after pregnancy in maternal thyroid tissue48 and speculate that fetal cells may upregulate maternal body temperature in women with newborn infants.6 Finally, based on evidence that fetal cells in maternal mouse brains can differentiate into mature neurons49 and that cFMC may be found in the female human brain,50 they propose an evolutionary role for cFMC in strengthening the emotional tie between mother and child.6The impact of cFMC in inducing immunotolerance during pregnancy and temporary secondary effects on autoimmune disease\nIn addition to modulating maternal body function postpartum, maternal acquisition of fetal genetic material has been proposed to play a role in inducing materno-fetal tolerance during pregnancy, a factor potentially contributing to why certain autoimmune diseases, like rheumatoid arthritis (RA), are temporarily ameliorated during pregnancy.24 In 1993, a study by Nelson et al. looked into fetal–maternal disparity in HLA class II molecules,51 a concept illustrated in Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Because of this bidirectional transfer of cells, a woman may host cells of fetal origin from her pregnancies and cells of maternal origin from her own mother (Figure 1).2 Furthermore, the same woman might host other cells transferred from her mother during fetal life, including cells possibly stemming from older siblings, a vanishing twin, or prior maternal termination of pregnancy,2,8,9 and even cells of neither fetal nor maternal origin stemming from maternal blood transfusion.9 Not all papers, however, demonstrate increased cFMC of older sibling origin, and further research is needed to uncover all potential sources of microchimerism in women.10\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "With both methods, the Y-chromosome is still often employed as a target for identifying microchimeric cells (Figure 2).2 FISH visualizes the cells in the context of surrounding maternal tissue, but is costly and time consuming.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Real-time PCR is simpler and more time efficient.11 With either method, the researcher may compare not only the prevalence of cFMC in different groups but also whether the relative quantities of cFMC differ in each subject (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This allows for microchimerism detection by FISH or by qPCR probes targeting the Y-chromosome (as shown here).Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "These probes are used to target paternally inherited fetal DNA sequences that the mother does not possess (Figure 4), thereby detecting microchimerism from male and female fetuses.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Boddy et al. hypothesize that cFMC may affect lactation, maternal thermoregulation, and mother–child bonding.6 Firstly, they cite a study showing that fetal microchimeric fibroblasts from mice differentiate into mammary epithelial cells when exposed to lactation hormones in vitro46 and another study showing that 56% of healthy parous women carry cFMC in their mammary tissue.47 Secondly, they present evidence that cFMC persists after pregnancy in maternal thyroid tissue48 and speculate that fetal cells may upregulate maternal body temperature in women with newborn infants.6 Finally, based on evidence that fetal cells in maternal mouse brains can differentiate into mature neurons49 and that cFMC may be found in the female human brain,50 they propose an evolutionary role for cFMC in strengthening the emotional tie between mother and child.6The impact of cFMC in inducing immunotolerance during pregnancy and temporary secondary effects on autoimmune disease\nIn addition to modulating maternal body function postpartum, maternal acquisition of fetal genetic material has been proposed to play a role in inducing materno-fetal tolerance during pregnancy, a factor potentially contributing to why certain autoimmune diseases, like rheumatoid arthritis (RA), are temporarily ameliorated during pregnancy.24 In 1993, a study by Nelson et al. looked into fetal–maternal disparity in HLA class II molecules,51 a concept illustrated in Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Because of this bidirectional transfer of cells, a woman may host cells of fetal origin from her pregnancies and cells of maternal origin from her own mother (Figure 1).2 Furthermore, the same woman might host other cells transferred from her mother during fetal life, including cells possibly stemming from older siblings, a vanishing twin, or prior maternal termination of pregnancy,2,8,9 and even cells of neither fetal nor maternal origin stemming from maternal blood transfusion.9 Not all papers, however, demonstrate increased cFMC of older sibling origin, and further research is needed to uncover all potential sources of microchimerism in women.10\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "With both methods, the Y-chromosome is still often employed as a target for identifying microchimeric cells (Figure 2).2 FISH visualizes the cells in the context of surrounding maternal tissue, but is costly and time consuming.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Real-time PCR is simpler and more time efficient.11 With either method, the researcher may compare not only the prevalence of cFMC in different groups but also whether the relative quantities of cFMC differ in each subject (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This allows for microchimerism detection by FISH or by qPCR probes targeting the Y-chromosome (as shown here).Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "These probes are used to target paternally inherited fetal DNA sequences that the mother does not possess (Figure 4), thereby detecting microchimerism from male and female fetuses.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Boddy et al. hypothesize that cFMC may affect lactation, maternal thermoregulation, and mother–child bonding.6 Firstly, they cite a study showing that fetal microchimeric fibroblasts from mice differentiate into mammary epithelial cells when exposed to lactation hormones in vitro46 and another study showing that 56% of healthy parous women carry cFMC in their mammary tissue.47 Secondly, they present evidence that cFMC persists after pregnancy in maternal thyroid tissue48 and speculate that fetal cells may upregulate maternal body temperature in women with newborn infants.6 Finally, based on evidence that fetal cells in maternal mouse brains can differentiate into mature neurons49 and that cFMC may be found in the female human brain,50 they propose an evolutionary role for cFMC in strengthening the emotional tie between mother and child.6The impact of cFMC in inducing immunotolerance during pregnancy and temporary secondary effects on autoimmune disease\nIn addition to modulating maternal body function postpartum, maternal acquisition of fetal genetic material has been proposed to play a role in inducing materno-fetal tolerance during pregnancy, a factor potentially contributing to why certain autoimmune diseases, like rheumatoid arthritis (RA), are temporarily ameliorated during pregnancy.24 In 1993, a study by Nelson et al. looked into fetal–maternal disparity in HLA class II molecules,51 a concept illustrated in Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Because of this bidirectional transfer of cells, a woman may host cells of fetal origin from her pregnancies and cells of maternal origin from her own mother (Figure 1).2 Furthermore, the same woman might host other cells transferred from her mother during fetal life, including cells possibly stemming from older siblings, a vanishing twin, or prior maternal termination of pregnancy,2,8,9 and even cells of neither fetal nor maternal origin stemming from maternal blood transfusion.9 Not all papers, however, demonstrate increased cFMC of older sibling origin, and further research is needed to uncover all potential sources of microchimerism in women.10\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "With both methods, the Y-chromosome is still often employed as a target for identifying microchimeric cells (Figure 2).2 FISH visualizes the cells in the context of surrounding maternal tissue, but is costly and time consuming.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Real-time PCR is simpler and more time efficient.11 With either method, the researcher may compare not only the prevalence of cFMC in different groups but also whether the relative quantities of cFMC differ in each subject (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This allows for microchimerism detection by FISH or by qPCR probes targeting the Y-chromosome (as shown here).Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "These probes are used to target paternally inherited fetal DNA sequences that the mother does not possess (Figure 4), thereby detecting microchimerism from male and female fetuses.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Boddy et al. hypothesize that cFMC may affect lactation, maternal thermoregulation, and mother–child bonding.6 Firstly, they cite a study showing that fetal microchimeric fibroblasts from mice differentiate into mammary epithelial cells when exposed to lactation hormones in vitro46 and another study showing that 56% of healthy parous women carry cFMC in their mammary tissue.47 Secondly, they present evidence that cFMC persists after pregnancy in maternal thyroid tissue48 and speculate that fetal cells may upregulate maternal body temperature in women with newborn infants.6 Finally, based on evidence that fetal cells in maternal mouse brains can differentiate into mature neurons49 and that cFMC may be found in the female human brain,50 they propose an evolutionary role for cFMC in strengthening the emotional tie between mother and child.6The impact of cFMC in inducing immunotolerance during pregnancy and temporary secondary effects on autoimmune disease\nIn addition to modulating maternal body function postpartum, maternal acquisition of fetal genetic material has been proposed to play a role in inducing materno-fetal tolerance during pregnancy, a factor potentially contributing to why certain autoimmune diseases, like rheumatoid arthritis (RA), are temporarily ameliorated during pregnancy.24 In 1993, a study by Nelson et al. looked into fetal–maternal disparity in HLA class II molecules,51 a concept illustrated in Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Because of this bidirectional transfer of cells, a woman may host cells of fetal origin from her pregnancies and cells of maternal origin from her own mother (Figure 1).2 Furthermore, the same woman might host other cells transferred from her mother during fetal life, including cells possibly stemming from older siblings, a vanishing twin, or prior maternal termination of pregnancy,2,8,9 and even cells of neither fetal nor maternal origin stemming from maternal blood transfusion.9 Not all papers, however, demonstrate increased cFMC of older sibling origin, and further research is needed to uncover all potential sources of microchimerism in women.10\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Because of this bidirectional transfer of cells, a woman may host cells of fetal origin from her pregnancies and cells of maternal origin from her own mother (Figure 1).2 Furthermore, the same woman might host other cells transferred from her mother during fetal life, including cells possibly stemming from older siblings, a vanishing twin, or prior maternal termination of pregnancy,2,8,9 and even cells of neither fetal nor maternal origin stemming from maternal blood transfusion.9 Not all papers, however, demonstrate increased cFMC of older sibling origin, and further research is needed to uncover all potential sources of microchimerism in women.10.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "With both methods, the Y-chromosome is still often employed as a target for identifying microchimeric cells (Figure 2).2 FISH visualizes the cells in the context of surrounding maternal tissue, but is costly and time consuming.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Real-time PCR is simpler and more time efficient.11 With either method, the researcher may compare not only the prevalence of cFMC in different groups but also whether the relative quantities of cFMC differ in each subject (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "This allows for microchimerism detection by FISH or by qPCR probes targeting the Y-chromosome (as shown here).Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "These probes are used to target paternally inherited fetal DNA sequences that the mother does not possess (Figure 4), thereby detecting microchimerism from male and female fetuses.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "With both methods, the Y-chromosome is still often employed as a target for identifying microchimeric cells (Figure 2).2 FISH visualizes the cells in the context of surrounding maternal tissue, but is costly and time consuming.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Real-time PCR is simpler and more time efficient.11 With either method, the researcher may compare not only the prevalence of cFMC in different groups but also whether the relative quantities of cFMC differ in each subject (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "These probes are used to target paternally inherited fetal DNA sequences that the mother does not possess (Figure 4), thereby detecting microchimerism from male and female fetuses.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The impact of cFMC in inducing immunotolerance during pregnancy and temporary secondary effects on autoimmune disease\nIn addition to modulating maternal body function postpartum, maternal acquisition of fetal genetic material has been proposed to play a role in inducing materno-fetal tolerance during pregnancy, a factor potentially contributing to why certain autoimmune diseases, like rheumatoid arthritis (RA), are temporarily ameliorated during pregnancy.24 In 1993, a study by Nelson et al. looked into fetal–maternal disparity in HLA class II molecules,51 a concept illustrated in Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In addition to modulating maternal body function postpartum, maternal acquisition of fetal genetic material has been proposed to play a role in inducing materno-fetal tolerance during pregnancy, a factor potentially contributing to why certain autoimmune diseases, like rheumatoid arthritis (RA), are temporarily ameliorated during pregnancy.24 In 1993, a study by Nelson et al. looked into fetal–maternal disparity in HLA class II molecules,51 a concept illustrated in Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  }
]